Psychiatry drugs finally have pharma’s attention. Can they keep it?
PharmaVoice,
Even for the most deep-pocketed drug companies, $14 billion dollars is no small investment.
Even for the most deep-pocketed drug companies, $14 billion dollars is no small investment.
Even for the most deep-pocketed drug companies, $14 billion dollars is no small investment.
. Neuroimmune Biomarkers in Mental Illness. Curr Top Behav Neurosci. 2018 Apr 7; PubMed.